Occult Hepatitis B: Clinical Implications and Treatment Decisions
- 228 Downloads
First reported in 1978, occult hepatitis B is a term used to describe the presence of hepatitis B virus (HBV) DNA without hepatitis B surface antigenemia. The prevalence of occult HBV is unclear and depends in part on the sensitivity of the hepatitis B surface antigen (HBsAg) and DNA assays used as well as the prevalence of HBV infection in the study population. The origin of occult HBV also remains in question. Several mechanisms have been hypothesized including mutations in the regulatory regions of the HBV genome, persistence of Ig-bound HBV immune complexes, viral interference, and blockage of free HBsAg secretion. Occult HBV has important clinical implications such as transmission through blood transfusion, reactivation in the setting of immunosuppression, and interference with hepatitis C treatment. To date, there is little data pertaining to the treatment of occult HBV outside of the setting of chemotherapy-induced HBV reactivation.
KeywordsOccult HBV Chronic hepatitis B HBV DNA HBs antigenemia
- 12.Weinberger K, Bauer T, Bohm S, et al. High genetic variability of the group specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J General Virol. 2000;81:1165–1174.Google Scholar
- 21.Fukuda R, Ishimura N, Hamamoto S, et al. Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver. J Med Virol. 2001;63:220–227.CrossRefPubMedGoogle Scholar
- 35.Meeting report. The management of chronic hepatitis B in the immunocompromised patient: Recommendations from a single topic meeting. J Clin Virol. 2008;41:243–254.Google Scholar